Personalized, multivalent, and more affordable: the globalization of vaccines

Clin Cancer Res. 2005 Aug 15;11(16):5663-4. doi: 10.1158/1078-0432.CCR-05-1101.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / immunology*
  • Cancer Vaccines / economics
  • Cancer Vaccines / immunology*
  • Cancer Vaccines / therapeutic use
  • Glioma / drug therapy
  • Glioma / immunology*
  • HLA-A Antigens / immunology
  • HLA-A2 Antigen / immunology
  • HLA-A24 Antigen
  • Humans
  • Leukocytes, Mononuclear / immunology
  • Peptides / immunology*
  • Peptides / therapeutic use
  • T-Lymphocytes, Cytotoxic / immunology
  • Treatment Outcome

Substances

  • Cancer Vaccines
  • HLA-A Antigens
  • HLA-A2 Antigen
  • HLA-A24 Antigen
  • Peptides